| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Across the recent three months, 20 analysts have shared their insights on Accenture (NYSE:ACN), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 9 | 4 | 7 | 0 | 0 |
| Last 30D | 1 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 0 | 2 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 7 | 4 | 4 | 0 | 0 |
Analysts have set 12-month price targets for Accenture, revealing an average target of $383.65, a high estimate of $445.00, and a low estimate of $275.00. A decline of 0.88% from the prior average price target is evident in the current average.
In examining recent analyst actions, we gain insights into how financial experts perceive Accenture. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Surinder Thind | Jefferies | Lowers | Hold | $275.00 | $340.00 |
| Jason Kupferberg | B of A Securities | Lowers | Buy | $365.00 | $419.00 |
| Jonathan Lee | Guggenheim | Maintains | Buy | $395.00 | $395.00 |
| David Koning | Baird | Lowers | Neutral | $345.00 | $372.00 |
| Bryan Keane | Deutsche Bank | Lowers | Hold | $295.00 | $409.00 |
| Ashwin Shirvaikar | Citigroup | Lowers | Buy | $400.00 | $430.00 |
| Keith Bachman | BMO Capital | Lowers | Market Perform | $375.00 | $385.00 |
| James Faucette | Morgan Stanley | Lowers | Overweight | $400.00 | $417.00 |
| Bryan Bergin | TD Cowen | Lowers | Market Perform | $350.00 | $363.00 |
| Daniel Perlin | RBC Capital | Raises | Outperform | $381.00 | $374.00 |
| Dan Dolev | Mizuho | Lowers | Buy | $398.00 | $426.00 |
| Arvind Ramnani | Piper Sandler | Lowers | Neutral | $379.00 | $394.00 |
| Alex Haissl | Redburn Atlantic | Raises | Buy | $445.00 | $410.00 |
| Jonathan Lee | Guggenheim | Announces | Buy | $425.00 | - |
| James Faucette | Morgan Stanley | Raises | Overweight | $417.00 | $400.00 |
| David Grossman | Stifel | Raises | Buy | $395.00 | $363.00 |
| Arvind Ramnani | Piper Sandler | Raises | Neutral | $394.00 | $335.00 |
| Ashwin Shirvaikar | Citigroup | Raises | Buy | $430.00 | $385.00 |
| Moshe Katri | Wedbush | Raises | Outperform | $400.00 | $360.00 |
| Bryan Keane | Deutsche Bank | Raises | Buy | $409.00 | $377.00 |
For valuable insights into Accenture's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Accenture analyst ratings.
Accenture is a leading global IT-services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Decline in Revenue: Over the 3 months period, Accenture faced challenges, resulting in a decline of approximately -0.09% in revenue growth as of 29 February, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Accenture's net margin excels beyond industry benchmarks, reaching 10.6%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Accenture's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 6.23%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.26%, the company showcases effective utilization of assets.
Debt Management: Accenture's debt-to-equity ratio is below the industry average. With a ratio of 0.12, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ACN
